Drug-coated stent for narrowed vertebral arteries
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether a drug-coated stent placed in a narrowed vertebral artery can improve outcomes for people with artery narrowing from plaque. It also looks at how safe the stent is, since it requires specific blood-thinning medicines around the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old (any gender)
- Have a narrowed vertebral artery from plaque (atherosclerotic vertebral artery stenosis)
- Be able and willing to understand the study and sign informed consent
- Be able to take two blood-thinning medicines (dual antiplatelet therapy) unless your doctor says it’s unsafe
- No major bleeding risk—such as active stomach/intestinal bleeding
- Not have certain recent major strokes/heart attacks, uncontrolled blood pressure, or serious short life expectancy (<12 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if placing a drug-coated stent in a narrowed artery in the neck, followed by a shorter course of two blood thinners, can better prevent another stroke in people with symptomatic vertebral artery stenosis.
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
This study tests a special stent that slowly releases a drug (rapamycin) to keep a narrowed brain artery open. It is for patients who have had strokes despite medical treatment.
This trial tests a new stent (a tiny mesh tube) coated with a drug called rapamycin to open up a severely narrowed artery in your brain. It's for people who have had a stroke or mini-stroke recently and haven't gotten better with blood thinners alone.
This trial tests whether a drug-coated balloon can safely open a severely blocked brain artery (at least 70% blocked) that remains symptomatic despite medication. It is designed for people who have not had a recent stroke or other major health problems.
This trial tests a special balloon catheter coated with a drug (sirolimus) to treat narrowed arteries inside the brain caused by atherosclerosis (plaque buildup). The goal is to keep the artery open and prevent future strokes.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.